Transcription of 2020 Annual Report
{{id}} {{{paragraph}}}
2020 Annual ReportOur MissionTo discover, develop and deliver innovative medicines that help patients prevail over serious diseasesOur VisionTo be the world's leading biopharma company that transforms patients' lives through scienceOur ValuesIntegrity | Innovation | Urgency | Passion | Accountability | InclusionCover image: During a year when most of us were separated by the pandemic, our global collective efforts ensured that individual contributions came together to make a significant impact for Full-Year RevenuesGAAP Full-Year Change vs. Prior Year*63%Worldwide Revenues$ Forma Full-Year Change vs. Prior Year**7% We created a leading biopharma company that combines the agility of a biotech company with the reach and resources of an established pharmaceutical corporation. We worked hard to deliver on our mission by maintaining an uninterrupted supply of medicines to patients, launching new products and continuing to conduct clinical trials where possible, while navigating the challenges of a worldwide pandemic.
with hypertrophic cardiomyopathy (HCM), a condition in which the muscle of the heart becomes abnormally thickened, making it difficult for the heart to pump blood. During his early school days, Ben had a low tolerance for exercise and temperature extremes, but his HCM remained stable–until he was 11 years old.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Ultrasound, Hypertrophic obstructive cardiomyopathy, Hypertrophic, Echocardiographic assessment of valve stenosis, Dobutamine, Cardiomyopathy, Obstructive hypertrophic cardiomyopathy, Obstructive cardiomyopathy Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy, Obstructive, Heart Disease Prediction System Using Machine